• Exchange: Stockholm
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech


127.7500 SEK 0.2500 0.20%

As of 11:29:59 ET on 09/22/2014.

Snapshot for Medivir AB (MVIRB)

Open: 127.2500 Day's Range: 126.5000 - 128.7500 Volume: 140,131
Previous Close: 127.5000 52wk Range: 77.7500 - 151.0000 1-Yr Rtn: +38.11%

Stock Chart for MVIRB

No chart data available.
  • MVIRB:SS 127.7500
  • 1D
  • 1M
  • 1Y
Interactive MVIRB Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for MVIRB

Current P/E Ratio (ttm) 6.4122
Estimated P/E(12/2014) 3.2168
Relative P/E vs. OMX 0.3991
Earnings Per Share (SEK) (ttm) 19.8451
Est. EPS (SEK) (12/2014) 39.5580
Est. PEG Ratio -
Market Cap (M SEK) 3,977.84
Shares Outstanding (M) 30.60
30 Day Average Volume 190,920
Price/Book (mrq) 2.7265
Price/Sale (ttm) 3.9955
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/20/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for MVIRB

  • Revenue
  • Net Income (M/SEK)
  • Profit Margin (%)

Company Profile & Key Executives for MVIRB

Medivir AB is a medical research company. The Company develops new drugs and pharmaceutical compounds based on proteases and polymerases as target enzymes. Medivir focuses on infectious and immunological diseases including projects against HIV, jaundice, shingles, multiple sclerosis, and rheumatoid arthritis. The Company is located in Huddinge, Sweden and Cambridge, United Kingdom.

Niklas PragerPresident/CEOChristina KassbergExec VP:Finance & Administration
Paul WallaceExec VP:Business DevelopmentRein PiirExec VP:Corporate Affairs
More Company Profile & Key Executives for MVIRB

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil